OmniStar Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,344
Closed -$1.39M 114
2021
Q2
$1.39M Buy
+12,344
New +$1.39M 1.72% 10
2018
Q4
Sell
-15,188
Closed -$917K 103
2018
Q3
$917K Buy
+15,188
New +$1.44M 0.7% 49

Other funds holding ABBV

OmniStar Financial Group's ABBV Position: Q2 2026 in Review

OmniStar Financial Group increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $204K and bringing the position to 10,199 shares worth $2.57M. The position accounts for 1.18% of the portfolio, ranked #26.

OmniStar Financial Group first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.95M in Q4 2019. 1,843 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • OmniStar Financial Group held 10,199 shares of AbbVie worth $2.57M as of Q2 2026.
  • OmniStar Financial Group bought 947 AbbVie shares in Q2 2026, an estimated $204K.
  • AbbVie made up 1.18% of OmniStar Financial Group's portfolio in Q2 2026, its #26 holding.
  • OmniStar Financial Group first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
  • OmniStar Financial Group's AbbVie position peaked at $2.95M in Q4 2019.
  • 1,843 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.